The disastrous spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has induced severe public healthcare issues and weakened the global economy …

The emergence of SARS-CoV-2 has seriously affected the lives of people worldwide.
Clarifying the attenuation rule of SARS-CoV-2 neutralizing antibody (NAb) in vivo is the key …

Abstract Background Neutralizing antibodies (NAbs) prevent pathogens from infecting host
cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor …

In this review, we provide an overview of developments in point-of-care (POC) diagnostics
during the COVID-19 pandemic. We review these advances within the framework of a …

Background As vaccines against SARS-CoV-2 are now being rolled out, a better
understanding of immunity to the virus, whether from infection, or passive or active …

ABSTRACT Background: Rapid Lateral Flow Test (LFT) has been broadly utilized in
detection or diagnosis of numerous disease-related antigens and antibodies. It is the most …

Vaccination is an effective strategy to fight COVID-19. However, the effectiveness of the
vaccine varies among different populations in varying immune effects. Neutralizing antibody …

Rapid diagnosis of coronavirus disease 2019 (COVID-19) is key for the long-term control of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) amid renewed threats of …

Current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines, based
on the ancestral Wuhan strain, were developed rapidly to meet the needs of a devastating …

Introduction Neutralizing antibodies (NAbs) are essential for preventing reinfection with
SARS-CoV-2 and the recurrence of COVID-19; nonetheless, the formation of NAbs following …